Elastomeric infusion pumps for outpatient parenteral antimicrobial therapy

Published on 1 Apr 2025

Last Updated on 1 Apr 2025

Guidance Recommendations

The Ministry of Health’s Medical Technology Advisory Committee has recommended elastomeric infusion pumps (EIPs) for patients requiring intravenous antimicrobials in line with the following criteria:

• Treatment is offered in non-inpatient settings, including the outpatient parenteral antimicrobial therapy (OPAT) clinic and at home;

• Treatment is supervised or supported by a multidisciplinary OPAT team;

• The individual or caregiver has received adequate education and training, and is assessed by the OPAT team to be capable of adhering to the prescribed treatment regimen; AND

• The antimicrobial used is shown to be stable with the EIP, based on reliable information sources including but not limited to, drug stability data compiled by the EIP manufacturer, HSA-approved antimicrobial product leaflets, and published drug stability studies.

Funding status

EIPs are recommended for subsidy for OPAT patients requiring intravenous antimicrobials, in line with the abovementioned recommendations.

Elastomeric Infusion Pumps for outpatient parenteral antimicrobial therapy (Published 1 Apr 2025)